» Articles » PMID: 6805013

Tryptophan Tolerance and Metabolism in Endogenous Depression

Overview
Specialty Pharmacology
Date 1982 Jan 1
PMID 6805013
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

The concentration of free and total tryptophan and kynurenine in plasma from 49 female depressives and 26 female controls was measured following oral loading with L-tryptophan, 100 mg/kg body weight. There was no significant difference between five depressives and six controls in the area under curve for free or total tryptophan or kynurenine in plasma. The peak concentration of kynurenine occurred 4 h after loading and in correlated significantly with the area under curve for kynurenine. There was no significant correlation between the L-tryptophan dose (g) and the plasma concentration of kynurenine a 4 h in the 49 depressives or 26 controls. The mean plasma levels of tryptophan and kynurenine at 4 h in the depressives were not significantly different from control levels. There was no clear relationship between the plasma levels of tryptophan or kynurenine at 4 h and the therapeutic response in 13 depressives treated with L-tryptophan for 15 days. It is concluded that the absorption, the plasma clearance, and the degradation to kynurenine of loading doses of L-tryptophan are normal in depressed patients. Results furthermore suggest that the plasma levels of tryptophan and kynurenine at 4 h are poor predictors of the response to L-tryptophan treatment in depressives.

Citing Articles

The tryptophan catabolite or kynurenine pathway in major depressive and bipolar disorder: A systematic review and meta-analysis.

Almulla A, Thipakorn Y, Vasupanrajit A, Algon A, Tunvirachaisakul C, Hashim Aljanabi A Brain Behav Immun Health. 2022; 26:100537.

PMID: 36339964 PMC: 9630622. DOI: 10.1016/j.bbih.2022.100537.


Microglial Dysregulation and Suicidality: A Stress-Diathesis Perspective.

Baharikhoob P, Kolla N Front Psychiatry. 2020; 11:781.

PMID: 32848946 PMC: 7432264. DOI: 10.3389/fpsyt.2020.00781.


Kynurenine and depressive symptoms in a poststroke population.

Bensimon K, Herrmann N, Swardfager W, Yi H, Black S, Gao F Neuropsychiatr Dis Treat. 2014; 10:1827-35.

PMID: 25285006 PMC: 4181733. DOI: 10.2147/NDT.S65740.


Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways.

Maes M, Berk M, Goehler L, Song C, Anderson G, Galecki P BMC Med. 2012; 10:66.

PMID: 22747645 PMC: 3391987. DOI: 10.1186/1741-7015-10-66.


Inflammation-associated depression: from serotonin to kynurenine.

Dantzer R, OConnor J, Lawson M, Kelley K Psychoneuroendocrinology. 2010; 36(3):426-36.

PMID: 21041030 PMC: 3053088. DOI: 10.1016/j.psyneuen.2010.09.012.


References
1.
Gal E . Cerebral tryptophan-2,3-dioxygenase (pyrrolase) and its induction in rat brain. J Neurochem. 1974; 22(5):861-3. DOI: 10.1111/j.1471-4159.1974.tb04306.x. View

2.
Hamilton M . Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967; 6(4):278-96. DOI: 10.1111/j.2044-8260.1967.tb00530.x. View

3.
Moller S . A method for the separation of plasma amino acids by ion-exchange chromatography combined with a semi-automatic computation of plasma amino acid concentrations. J Chromatogr. 1975; 104(1):63-72. DOI: 10.1016/s0021-9673(01)85488-1. View

4.
James J, Hodgman J, Funovics J, Yoshimura N, Fischer J . Brain tryptophan, plasma free tryptophan and distribution of plasma neutral amino acids. Metabolism. 1976; 25(4):471-6. DOI: 10.1016/0026-0495(76)90080-9. View

5.
Moller S, Kirk L, FREMMING K . Plasma amino acids as an index for subgroups in manic depressive psychosis: correlation to effect of tryptophan. Psychopharmacology (Berl). 1976; 49(2):205-13. DOI: 10.1007/BF00427292. View